Aflac Inc Stock Price, News & Analysis

Aflac (NYSE:AFL) launches its 2025 college football campaign featuring the Aflac Duck as the "Commissioner of Coverage," alongside coaches Nick Saban and Deion "Coach Prime" Sanders. The campaign includes two new commercials highlighting how Aflac helps cover medical expenses when health insurance falls short.

The campaign kicks off with the Aflac Kickoff Game doubleheader in Atlanta on August 30-31, featuring Tennessee vs. Syracuse and South Carolina vs. Virginia Tech. The first commercial "Commissioner of Coverage" debuts on ABC during the kickoff game, while "Everyone Wants Aflac" will air throughout the football season across multiple platforms.

Aflac (NYSE:AFL) has released its second annual Time Away Study, revealing significant challenges faced by employees covering for colleagues on leave. The study shows that 73% of employees experience workplace stress while covering for peers, and 41% face burnout during extended coverage periods over eight weeks.

Key findings highlight that mental well-being dropped 11 percentage points during coverage periods, with 27% of employees developing new health conditions attributed to increased workload. Despite 95% of leaders having access to recognition tools, 29% of employees received no recognition for additional work.

Aflac emphasizes the need for employers to implement proactive leave management strategies, including clear communication, regular check-ins, and support systems to prevent burnout and maintain productivity.

Aflac (NYSE: AFL) has announced a significant expansion of its share repurchase program. The company's Board of Directors has authorized the purchase of 100 million additional shares of common stock. This new authorization complements the existing 30.9 million shares remaining from the November 2022 authorization, bringing the total available for repurchase to approximately 130.9 million shares.

The company plans to execute these repurchases through open market or negotiated transactions, with timing dependent on market conditions.

Aflac (NYSE: AFL) reported Q2 2025 financial results with net earnings of $599 million ($1.11 per diluted share), down from $1.8 billion ($3.10 per share) in Q2 2024. Total revenues decreased to $4.2 billion from $5.1 billion year-over-year, primarily due to net investment losses of $421 million versus gains of $696 million in Q2 2024.

Key highlights include adjusted earnings of $957 million ($1.78 per diluted share), a 7.5% decrease from Q2 2024. Aflac Japan saw a 23.2% increase in new annualized premium sales to ¥20.7 billion, while Aflac U.S. reported a 2.7% sales growth to $340 million. The company declared a Q3 dividend of $0.58 per share and repurchased $829 million in shares during Q2.

The average yen/dollar exchange rate strengthened 7.7% to 144.60, positively impacting adjusted earnings per share by $0.04.

Aflac (NYSE:AFL) has announced the schedule for its second quarter 2025 financial results release and related events. The company will release its Q2 2025 results after market close on August 5, 2025, accompanied by earnings materials and a financial update video from CFO Max Brodén on their investor relations website.

A conference call webcast is scheduled for August 6, 2025, at 8:00 a.m. ET, where CEO Daniel P. Amos and CFO Max Brodén will discuss quarterly results. Aflac U.S. President Virgil Miller will join to answer questions alongside other executive management members from U.S. and Japan operations.

Aflac Incorporated (NYSE: AFL) disclosed a cybersecurity incident detected on June 12, 2025, where unauthorized access was gained through social engineering tactics. The company stopped the intrusion within hours and confirmed no ransomware was involved. The attack was part of a broader cybercrime campaign targeting the insurance industry. While business operations remain functional, preliminary findings indicate potentially compromised data includes claims information, health information, social security numbers, and personal information of customers, beneficiaries, employees, and agents. As a precautionary measure, Aflac is offering free 24-month credit monitoring, identity theft protection, and Medical Shield to affected individuals through a dedicated call center at 1-855-361-0305.

Aflac (AFL) is expanding its partnership with Empathy to offer LifeVault™, a digital legacy planning platform, to select group term life insurance certificate holders at no additional cost starting July 1, 2025. LifeVault enables customers to create and manage essential end-of-life documents including wills, advance health care directives, power of attorney, and funeral directives.

This expansion builds upon Empathy's loss support service introduced to Aflac customers in July 2024. The platform streamlines legacy planning, making it more accessible and ensuring members can protect their healthcare, finances, and wishes. The will creation process can typically be completed in under 15 minutes, offering an efficient solution for comprehensive end-of-life planning.

The partnership aims to help families navigate loss and plan for the future, reinforcing Aflac's commitment to supporting customers through challenging life moments.

Aflac reported significant changes in its Q1 2025 financial performance. Total revenues decreased to $3.4 billion from $5.4 billion year-over-year, primarily due to net investment losses of $963 million compared to gains of $951 million in Q1 2024. Net earnings dropped to $29 million ($0.05 per share) from $1.9 billion ($3.25 per share).

Key highlights:

• Adjusted earnings reached $906 million, down 5.7% from Q1 2024
• Japan sales increased 12.6% to ¥14.1 billion ($93 million)
• U.S. sales grew 3.5% to $309 million
• Board declared Q2 dividend of $0.58 per share
• Company repurchased 8.5 million shares for $900 million

The company maintained strong capital position with shareholders' equity at $26.3 billion ($48.55 per share). Despite challenges, Aflac showed resilience in both Japanese and U.S. markets, with improved sales and stable premium persistency rates of 93.8% and 79.3% respectively.

Aflac's 2025 Wellness Matters Survey reveals concerning trends in preventive healthcare, with 90% of Americans postponing vital health checkups and screenings. The survey highlights that 94% of Americans face barriers to getting recommended screenings within suggested timeframes.

Key findings show that 48% of Americans face logistical barriers like work conflicts, while 40% have canceled appointments due to long wait times. Generation Z reports high levels of personal embarrassment (32%) and doctor distrust. Common avoided screenings include pap smears (33%), prostate exams (32%), and colonoscopies (32%), with millennials (62%) and Gen Z (61%) being most likely to avoid screenings.

The survey also reveals that 65% of Americans only realize the importance of proactive health care after experiencing a health scare. Notably, nearly 1 in 5 Americans lacks a primary care physician, with 41% primarily using urgent care or emergency rooms for medical needs.